Decision aid for gender-affirming surgeries
Part of Mental health clinical trials.
This study tests an online decision tool for people considering metoidioplasty or phalloplasty. The tool helps patients compare surgical options to make informed choices.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were assigned female at birth and identify as a trans man or gender non-binary.
- You are 18 or older.
- You live in the United States.
- You can read and understand English at a sixth-grade level (for example, most news articles).
- You are either thinking about getting metoidioplasty or phalloplasty, or have already had one of these surgeries.
- If you join the main part of the study, you must have a consultation scheduled for metoidioplasty or phalloplasty.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how transgender men and their partners use erectile aids after phalloplasty or metoidioplasty. It hopes to improve sexual health and satisfaction after surgery.
This study looks at people who are preparing to start gender-affirming hormone treatment. It may help researchers understand what support is needed before hormones begin.
This study asks people who are planning genital gender-affirming surgery to report how their genital sensitivity and sexual function feel afterward. It helps doctors understand what changes patients experience and improve follow-up care.
This study looks at bladder and urinary symptoms (like leaking or frequent urination) in transmasculine people who are having metoidioplasty or phalloplasty surgery. It also tests whether participants find pelvic floor muscle training (exercises to strengthen the muscles that control urination) helpful and acceptable.
This study is testing whether using a 3D model of the surgical site helps patients better understand vaginoplasty surgery, which creates a vagina. It looks at whether the 3D model improves education and surgical outcomes compared to standard care.
This study looks at starting gender-affirming hormone therapy (GAHT) for transgender people who have never had these treatments before. It may help you learn whether this approach is safe and effective for your goals as you begin care.
Hear when a new Gender Dysphoria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.